Evidence map›Paper›PMID 23303911›Full record

ReviewPhysiological reviews2013

Proteins and small molecules for cellular regenerative medicine.

Eric M Green, Richard T Lee

Abstract readReview
In one paragraph

Review in Physiological reviews, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Microenvironmental Modulation for Therapeutic Efficacy of Extracellular Vesicles.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Eric M GreenHarvard Stem Cell Institute and the Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Cambridge, Massachusetts 02139, USA.
Richard T Lee
Harvard University · US

Funding

Interleukin-33 and Myocardial Pressure OverloadR01HL092930 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LEE, RICHARD T · 2009 to 2013
$2.0M
Aging and Myocardial Progenitor RecruitmentR01AG032977 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI LEE, RICHARD T · 2009 to 2013
$1.9M
NHLBI NIH HHS HL092930NHLBI NIH HHS R01 HL092930NIA NIH HHS AG032977NIA NIH HHS R01 AG032977
6 · The paper itself

Abstract

Regenerative medicine seeks to understand tissue development and homeostasis and build on that knowledge to enhance regeneration of injured tissues. By replenishing lost functional tissues and cells, regenerative medicine could change the treatment paradigm for a broad range of degenerative and ischemic diseases. Multipotent cells hold promise as potential building blocks for regenerating lost tissues, but successful tissue regeneration will depend on comprehensive control of multipotent cells-differentiation into a target cell type, delivery to a desired tissue, and integration into a durable functional structure. At each step of this process, proteins and small molecules provide essential signals and, in some cases, may themselves act as effective therapies. Identifying these signals is thus a fundamental goal of regenerative medicine. In this review we discuss current progress using proteins and small molecules to regulate tissue regeneration, both in combination with cellular therapies and as monotherapy.

Indexed as

AnimalsCell DifferentiationCell MovementCell ProliferationCell SurvivalHematopoietic Stem CellsHematopoietic Stem Cell TransplantationHumansMesenchymal Stem CellsMesenchymal Stem Cell TransplantationPluripotent Stem CellsProteinsRegenerationRegenerative MedicineSignal TransductionStem Cell NicheProteins

Identifiers

PMID23303911
PMCPMC3781772
OpenAlexW2163834077

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.